Tracking the Putative Biosynthetic Precursors of Oxygenated Mycolates of Mycobacterium tuberculosis

Disruption of the mma4 gene (renamed hma) of Mycobacterium tuberculosis has yielded a mutant strain defective in the synthesis of both keto- and methoxymycolates, with an altered cell-wall permeability to small molecules and a decreased virulence in the mouse model of infection (Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M. A., Yu, K., Quémard, A., Smith, I., and Daffé, M. (2000) Mol. Microbiol. 36, 630–637). Assuming that the mutant would accumulate the putative precursors of the oxygenated mycolates of M. tuberculosis, a detailed structural analysis of mycolates from the hma-inactivated strain was performed using a combination of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, proton NMR spectroscopy, and chemical degradation techniques. These consisted most exclusively of α-mycolates, composed of equal amounts of C76-C82 dicyclopropanated (α1) and of C77-C79 monoethylenic monocyclopropanated (α2) mycolates, the double bond being located at the “distal” position. In addition, small amounts ofcis-epoxymycolates, structurally related to α2-mycolates, was produced by the mutant strain. Complementation of the hma-inactivated mutant with the wild-type gene resulted in the disappearance of the newly identified mycolates and the production of keto- and methoxymycolates of M. tuberculosis. Introduction of the hma gene inMycobacterium smegmatis led to the lowering of diethylenic α mycolates of the recipient strain and the production of keto- and hydroxymycolates. These data indicate that long-chain ethylenic compounds may be the precursors of the oxygenated mycolates of M. tuberculosis. Because the lack of production of several methyltransferases involved in the biosynthesis of mycolates is known to decrease the virulence of the tubercle bacillus, the identification of the substrates of these enzymes should help in the design of inhibitors of the growth of M. tuberculosis.

[1]  J. Sacchettini,et al.  Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.

[2]  M. Daffé,et al.  The envelope layers of mycobacteria with reference to their pathogenicity. , 1998, Advances in microbial physiology.

[3]  K. Takayama,et al.  Isoniazid Inhibition of the Synthesis of Monounsaturated Long-Chain Fatty Acids in Mycobacterium tuberculosis H37Ra , 1979, Antimicrobial Agents and Chemotherapy.

[4]  M. Daffé,et al.  Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto‐ and hydroxy‐mycolic acids , 1997, Molecular microbiology.

[5]  C. E. Barry,et al.  The specificity of methyl transferases involved in trans mycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. , 2001, Bioorganic chemistry.

[6]  A. Pugsley Molecular genetics in mycobacteria. , 1987, Microbiological sciences.

[7]  H. Marrakchi,et al.  InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. , 2000, Microbiology.

[8]  I. Smith,et al.  Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice , 2000, Molecular microbiology.

[9]  Y. Yuan,et al.  A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Tsuyoshi Fujita,et al.  Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. , 2002, Microbiology.

[11]  K. Takayama,et al.  Effect of Isoniazid on the In Vivo Mycolic Acid Synthesis, Cell Growth, and Viability of Mycobacterium tuberculosis , 1972, Antimicrobial Agents and Chemotherapy.

[12]  M. Daffé,et al.  Acide mycolique epoxydique: un nouveau type d'acide mycolique , 1981 .

[13]  B. Doz,et al.  Mise en évidence de séquences spécifiques sur le RNA3, RNA satellite du virus des anneaux noirs de la tomate , 1981 .

[14]  D. Minnikin,et al.  Studies on the mycolic acids from the walls of Mycobacterium microti. , 1982, Journal of general microbiology.

[15]  M. Daffé,et al.  Tetraenoic and pentaenoic mycolic acids from Mycobacterium thamnopheos. Structure, taxonomic and biosynthetic implications. , 1988, European journal of biochemistry.

[16]  W. Jacobs,et al.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.

[17]  M. Daffé,et al.  Structure of a hydroxymycolic acid potentially involved in the synthesis of oxygenated mycolic acids of the Mycobacterium tuberculosis complex. , 1997, European journal of biochemistry.

[18]  James C Sacchettini,et al.  Crystal Structures of Mycolic Acid Cyclopropane Synthases fromMycobacterium tuberculosis * , 2002, The Journal of Biological Chemistry.

[19]  D. Minnikin,et al.  The oxygenated mycolic acids of Mycobacterium fortuitum, M. Farcinogenes and M. Senegalense , 1982 .

[20]  B. Monsarrat,et al.  Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry. , 2001, Analytical chemistry.

[21]  D. Minnikin,et al.  Separation and characterization of individual mycolic acids in representative mycobacteria. , 2001, Microbiology.

[22]  F. Winder,et al.  Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. , 1970, Journal of general microbiology.

[23]  V. Levy-Frebault,et al.  Intérêt taxonomiquedes acides gras des mycobactéries: Proposition d'une méthode d'analyse , 1983 .

[24]  E. Lederer Some problems concerning biological C-alkylation reactions and phytosterol biosynthesis , 1969 .

[25]  H. Nikaido,et al.  The envelope of mycobacteria. , 1995, Annual review of biochemistry.

[26]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[27]  M. Strain,et al.  Three types of mycolic acid from Mycobacterium tuberculosis Brévanne: implications for structure-function relationships in pathogenesis , 1979, Journal of bacteriology.

[28]  E. Rudloff PERIODATE–PERMANGANATE OXIDATIONS: V. OXIDATION OF LIPIDS IN MEDIA CONTAINING ORGANIC SOLVENTS , 1956 .

[29]  D. Crane,et al.  The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis , 1998, Molecular microbiology.

[30]  M. Daffé,et al.  Etude structurale et métabolique des acides mycoliques de Mycobacterium fortuitum , 1987 .

[31]  R. Slayden,et al.  Mycolic acids: structure, biosynthesis and physiological functions. , 1998, Progress in lipid research.

[32]  M. Lanéelle,et al.  The biosynthesis of mycolic acids by Mycobacteria: current and alternative hypotheses. , 2002, Progress in lipid research.

[33]  D. Minnikin,et al.  Mycolic acid patterns of some species of Mycobacterium , 1984, Archives of Microbiology.

[34]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.